Sacubitril/Valsartan vs Standard Medical Therapies in Patients With Heart Failure and Preserved Ejection Fraction
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA: The Journal of the American Medical Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction: The PARALLAX Randomized Clinical Trial
JAMA 2021 Nov 16;326(19)1919-1929, B Pieske, R Wachter, SJ Shah, A Baldridge, P Szeczoedy, G Ibram, V Shi, Z Zhao, MR CowieFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.